MY113222A - Medicinal patches for percutaneous administration - Google Patents
Medicinal patches for percutaneous administrationInfo
- Publication number
- MY113222A MY113222A MYPI95004067A MYPI19954067A MY113222A MY 113222 A MY113222 A MY 113222A MY PI95004067 A MYPI95004067 A MY PI95004067A MY PI19954067 A MYPI19954067 A MY PI19954067A MY 113222 A MY113222 A MY 113222A
- Authority
- MY
- Malaysia
- Prior art keywords
- skin
- layer
- absorption capacity
- water absorption
- penetration enhancer
- Prior art date
Links
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 239000012790 adhesive layer Substances 0.000 abstract 3
- 239000003961 penetration enhancing agent Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229940051250 hexylene glycol Drugs 0.000 abstract 2
- 239000010410 layer Substances 0.000 abstract 2
- 239000004840 adhesive resin Substances 0.000 abstract 1
- 229920006223 adhesive resin Polymers 0.000 abstract 1
- 239000007933 dermal patch Substances 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
DISCLOSED HEREIN IS A TRANSDERMAL SKIN PATCH TO ADHERE TO A PATIENT''S SKIN, WHICH COMPRISES A WATER-IMPERMEABLE BACKING LAYER; A LINEAR; AND BETWEEN THE TWO, A MULTILAYER LAMINATED OF FROM 2 TO 5 ADHESIVE LAYER, EACH OF SAID ADHESIVE LAYERS COMPRISING AN ACTIVE INGREDIENT, AN ADHESIVE RESIN, AND A PENETRATION ENHANCER, WHEREIN EACH ADHESIVE LAYER CONTAINS NO WATER AND HAS A DIFFERENT WATER ABSORPTION CAPACITY IN WHICH THE LOWEST LAYER WHICH IS TO BE CONTACTED WITH THE SKIN HAS THE LOWEST WATER ABSORPTION CAPACITY AND THE MOST UPPER LAYER IN CONTACT WITH THE BACKING LAYER HAS THE HIGHEST WATER ABSORPTION CAPACITY, AND SAID PENETRATION ENHANCER BEING HEXYLENE GLYCOL PRESENT IN AN AMOUNT OF 0.5 TO 40BY WEIGHT THE PATCH OF THE PRESENT INVENTION CONTAINS HEXYLENE GLYCOL AS A PENETRATION ENHANCER, WHICH ALLOWS AN EFFICIENT ENHANCEMENT OF THE PENETRATION OF ACTIVE INGREDIENT THROUGH THE SKIN, AS WELL AS CAN BE APPLIED TO THE SKIN SAFELY.FIGURE 1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19940036654 | 1994-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY113222A true MY113222A (en) | 2001-12-31 |
Family
ID=19403420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI95004067A MY113222A (en) | 1994-12-24 | 1995-12-22 | Medicinal patches for percutaneous administration |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR100188180B1 (en) |
| MY (1) | MY113222A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19925613A1 (en) * | 1999-06-04 | 2000-12-07 | Lohmann Therapie Syst Lts | Composite laminate and process for its manufacture |
| KR100433614B1 (en) * | 2000-06-16 | 2004-05-31 | 주식회사 태평양 | Transdermal Preparation Containing Hydrophilic or Salt-form Drug |
| KR100376086B1 (en) * | 2000-10-18 | 2003-03-15 | 주식회사 태평양 | Film-forming agent for drug deliverly and preparation for percutaneous administration containing the same |
| DE02715112T1 (en) * | 2001-03-16 | 2007-04-19 | Alza Corp., Mountain View | TRANSDERMALES PLASTER FOR THE ADMINISTRATION OF FENTANYL |
| KR100663163B1 (en) | 2005-10-24 | 2007-01-02 | (주)아모레퍼시픽 | Transdermal Dosage Forms Containing Nonsteroidal Anti-inflammatory Drugs |
-
1995
- 1995-12-21 KR KR1019950053707A patent/KR100188180B1/en not_active Expired - Lifetime
- 1995-12-22 MY MYPI95004067A patent/MY113222A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100188180B1 (en) | 1999-06-01 |
| KR960021015A (en) | 1996-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4822617A (en) | Drug delivery device | |
| US5238933A (en) | Skin permeation enhancer compositions | |
| CA2064687A1 (en) | Method and device for administering dexmedetomidine transdermaly | |
| ZA951427B (en) | Drug containing adhesive composite transdermal delivery device | |
| CA2183960C (en) | Medicinal patches for percutaneous administration | |
| US5227169A (en) | Sorbitan esters as skin permeation enhancers | |
| WO2000033812A3 (en) | Transdermal patch for delivering volatile liquid drugs | |
| CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
| ATE127331T1 (en) | IMPLANTED TRANSDERMAL DRUG ADMINISTRATION ARRANGEMENT. | |
| EP0138551A3 (en) | A system for the transdermal delivery of nitroglycerin | |
| CS9005598A2 (en) | Method of transdermal therapeutic system's production with buprenorfin as active part | |
| ATE78183T1 (en) | DIFFUSION MATRIX FOR TRANSDERMAL PHARMACEUTICAL DELIVERY AND TRANSDERMAL PHARMACEUTICAL DELIVERY DEVICES INCLUDING THEM. | |
| NZ231908A (en) | Transdermal therapeutical system comprising physostigmine in a polymer-based reservoir layer | |
| CA2274895A1 (en) | Contour of a transdermal therapeutic system | |
| WO1993000788A3 (en) | A bandage for fixating a cannula of a venous catheter relative toa skin surface part of a person | |
| CA2122702A1 (en) | Protective barrier apparel fabric | |
| CA2387143A1 (en) | Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin | |
| MY111688A (en) | Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous) | |
| WO1994025025A3 (en) | Systems for controlled release of pilocarpine | |
| CA2288482A1 (en) | Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis | |
| US3901234A (en) | Combination plaster and metal spheres device | |
| JP3171935B2 (en) | Patch with excellent sticking properties | |
| JPH02139624U (en) | ||
| MY111373A (en) | Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof | |
| EP1449527A3 (en) | Transdermal patch for administering a volatile liquid drug |